They’re saving us from COVID-19, is influenza next for mRNA vaccines?
The technology could be revolutionary, with some scientists suggesting it could be used to treat cancers
Until last year, pharma company Moderna seemed to be a toxic investment story you read about only if you thumbed through the business pages of your newspaper.
It had been around for a decade without managing to get a single drug approved, it had lost about $2 billion and it was only sustained through the life-support of repeated capital raising.
